Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours

HIGHLIGHTS

SUMMARY

    In 2017, the WHO classification introduced lineage-based classification of pituitary tumours, as determined by transcription factor and hormonal immunohistochemistry (IHC). Pituitary stem_cells undergo lineage commitment into mature hormone-producing cell types (ACTH, LH, FSH, TSH, GH, PRL) following downregulation of stem_cell markers and upregulation of differentiation-specific transcription factors. Steroidogenic factor 1 (SF1) gives rise to gonadotroph cells; T-box transcription factor 19 (TPIT) gives rise to corticotroph cells and pituitary-specific positive transcription factor (PIT1) gives rise to lactotroph, somatotroph and thyrotroph cells (Fig 1). Adoption of transcription factor analysis has been . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?